Welcome to our dedicated page for Bankwell Financial Group SEC filings (Ticker: BWFG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Bankwell Financial Group, Inc.'s filings document the holding company's ownership of Bankwell Bank and recurring disclosures for a commercial banking issuer. Form 8-K reports furnish quarterly results of operations and financial condition, Regulation FD presentation materials, and trends in profitability, loan growth, deposits, funding costs, net interest margin, credit quality and SBA lending activity.
Definitive proxy materials cover annual meeting governance, director matters, executive compensation, equity awards and shareholder voting items. The filings also record the company's Connecticut incorporation, public-company identifiers, furnished earnings releases and exhibits used to report financial results and presentation materials.
Bankwell Financial Group, Inc. director Jeffrey R. Dunne reported buying 363 shares of common stock on December 5, 2025 at $47.64 per share through a deferred compensation plan, bringing his indirect holdings in that plan to 5,448 shares.
He also beneficially owns 3,033 shares of common stock directly, plus restricted stock granted under the 2022 Bankwell Financial Group, Inc. Stock Plan: 1,800 shares granted on February 7, 2025 that vest in three 600-share installments on February 7, 2026, February 7, 2027 and February 7, 2028, and 1,600 shares granted on December 29, 2023, with 533 shares vested on February 7, 2025 and additional 533- and 534-share tranches scheduled to vest on February 7, 2026 and February 7, 2027. As of the filing date, 533 of those 2023 grant shares have vested.
Bankwell Financial Group, Inc. (BWFG) reported an equity award to its CEO on a Form 4. On 11/18/2025, the CEO received 22,500 shares of common stock at a price of $0, granted under the 2022 Bankwell Financial Group, Inc. Stock Plan. These are performance restricted shares with a three-year cliff vesting on February 7, 2028, and they vest only if stated performance goals are achieved.
The filing also describes prior equity awards under the same plan that include time-based restricted stock vesting in three equal annual installments and additional performance restricted stock that may vest if separate performance goals are met. Some shares are held through an IRA and some are jointly owned with the CEO’s spouse, reflecting both incentive alignment and personal investment in the company’s stock.
Bankwell Financial Group (BWFG) reported insider activity by an officer. On 11/12/2025, the officer executed a sale of 2,553 shares of common stock at $45.52 per share. Following the transaction, the officer directly held 13,939 shares.
Additional beneficial holdings reflect equity awards: 1,470, 245, 490, 3,262, and 1,529 shares subject to time-based and performance vesting under the 2022 Stock Plan. Footnotes note scheduled vesting beginning on February 7 across 2025–2028 and performance-based cliff vesting. As of the filing, portions of prior grants had 1,090 and 2,295 shares vested and 542 and 765 shares forfeited, respectively.
Bankwell Financial Group (BWFG) reported stronger Q3 2025 results. Net income rose to $10,078 and diluted EPS reached $1.27 (basic $1.28). Net interest income improved to $25,987 as deposit interest expense eased year over year. The provision for credit losses was modest at $372, supporting a sharp rebound in profitability.
Noninterest income increased to $2,495, helped by higher gains and fees from sales of loans. Noninterest expense rose to $14,631, reflecting higher compensation and professional services. At quarter-end, loans receivable, net, were $2,684,016 and deposits totaled $2,757,415. Shareholders’ equity increased to $292,791 as accumulated other comprehensive loss narrowed to $(570). The company paid a quarterly dividend of $0.20 per share. As of October 31, 2025, shares outstanding were 7,877,443.
Bankwell Financial Group (BWFG) announced a quarterly dividend of $0.20 per share. The dividend is payable on November 21, 2025 to shareholders of record as of November 10, 2025.
The company also furnished materials related to its third‑quarter 2025 results. A press release outlining results and a slide presentation reviewing financial trends through September 30, 2025 were provided as Exhibits 99.1 and 99.2. These materials were furnished and not filed under the Exchange Act.
Seidman group disclosed ownership of 788,622 shares, or approximately 10.01% of Bankwell Financial Group Inc. The filing states the shares were acquired in open market purchases using working capital and cost about $22,038,633.14 including commissions. The ownership calculation is based on 7,877,443 shares outstanding as of June 30, 2025. The filing details individual holdings across affiliated entities: Seidman and Associates LLC (194,509 shares, 2.47%), Seidman Investment Partnership LP (133,370 shares, 1.69%), Seidman Investment Partnership II LP (172,234 shares, 2.19%), LSBK06-08 LLC (114,199 shares, 1.45%), Broad Park Investors LLC (129,711 shares, 1.65%), Chewy Gooey Cookies LP (21,419 shares, 0.27%), and Veteri Place Corporation (305,604 shares, 3.88% as general partner). The purchases were executed under regulatory approvals to acquire up to 14.99% of outstanding shares.
Lawrence B. Seidman, a director of Bankwell Financial Group, Inc. (BWFG), reported multiple transactions on 09/12/2025. The filing shows purchases totaling 17,000 common shares across six entities at prices between $45.91 and $45.93 per share. The report also records dispositions of 19,405 shares associated with restricted stock vesting and a deferred compensation plan. Aggregating the transactions, the report shows a net decrease of 2,405 shares on that date across the reporting person’s holdings.
The record lists the beneficial ownership balances for each reporting entity after the purchases (for example, 194,509, 133,370, 172,234, 114,199, 129,711, and 21,419 shares). Explanatory notes specify the restricted stock grants, vesting schedules, and the number of shares vested as of the filing date.
Lawrence B. Seidman, a director of Bankwell Financial Group, Inc. (BWFG), reported multiple transactions on 09/10/2025. He purchased blocks of common stock through several affiliated entities: 4,602 shares at $44.53, 1,502 shares at $44.54, 913 shares at $44.55, 2,700 shares at $44.54, 753 shares at $44.55 and 530 shares at $44.57; the Form shows the resulting beneficial ownership counts for each entity after those purchases. The filing also reports disposals tied to restricted stock vesting and a deferred compensation plan: 1,800 shares (granted 02/07/2025) with staged vesting through 2028, 1,067 shares (granted 12/29/2023) with 533 already vested, 800 shares (granted 12/30/2022) with 800 vested, 400 shares (granted 12/31/2021) with 1,200 vested to date, and a separate 15,338-share disposition related to a Deferred Compensation Plan. The Form 4 was signed by an attorney-in-fact on 09/11/2025.
Blake S. Drexler, a director of Bankwell Financial Group, Inc. (BWFG), reported multiple changes in his beneficial ownership on a Form 4 filed for transactions dated 09/04/2025. The filing shows a purchase of 170 shares of common stock at $42.45 per share. It also reports several dispositions from various accounts and awards, including 1,200 shares disposed from a deferred compensation plan, 1,067 shares and 800 shares disposed under other listed entries, and 158,928 shares disposed associated with an IRA-401(k) entry. The filing lists indirect beneficial ownership positions (for example 36,649 shares and 58,224 shares) and describes restricted stock grants from 2021–2025 with vesting schedules and amounts in the explanations.
Jeffrey R. Dunne, a director of Bankwell Financial Group, Inc. (BWFG), reported insider transactions on 09/04/2025. The filing shows a purchase of 407 shares of common stock at $42.45 per share, recorded with transaction code P. After the reported transactions, the filing lists 5,085 shares beneficially owned indirectly. The Form 4 also documents restricted stock grants described in the explanations: an 1,800-share grant dated February 7, 2025, vesting in three annual tranches of 600 shares, and a 1,600-share grant dated December 29, 2023, of which 533 shares vested on February 7, 2025 and the remaining vest over 2026–2027. The filing is signed by an attorney-in-fact on 09/05/2025.